{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:55:17Z","timestamp":1773467717822,"version":"3.50.1"},"reference-count":23,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Asthma is a chronic inflammatory disease of the small airways. Chronic\ninflammation often causes hyper responsiveness of airways with wheezing, breathing difficulty,\ncough and chest tightness.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The present study aimed to evaluate the drug usage pattern of anti-asthma drugs among\nasthma patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The present study was a prospective, observational cross-sectional study carried out\namong 422 outpatients being treated at the respiratory medicine department, SRM Medical College\nHospital and Research Centre. Data regarding the prescribing indicators and patient indicators\nwere collected from the patients\u2019 prescription slips and entered in the preformed proforma. Prescribing\nindicators were taken into consideration in evaluating the rationality of prescriptions.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>In the present study, 49% of patients were between the age group of 20-40 years. Genderwise\ndistribution showed 58.05% of males and 41.95% of females. A family history of asthma was\nseen in 68% of the study population. The present study reported smoking among 51% and tobacco\nchewing in 21% of the study population. Low economic strata were observed in 77.9% of the study\npopulation. According to asthma grading, 65.8% were in the mild intermittent, and 25% were in\nthe mild persistent group. Patients were on \u03b22 agonists (35.4%) and corticosteroids (32%). The\nmost commonly used fixed drug combination was a short-acting \u03b22 agonist with corticosteroid\n(40.5%). A total of 68% of drugs were used by the inhalational route and 29% by the oral route.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The findings showed that, the most frequently prescribed drug was a short-acting \u03b22\nagonist with corticosteroid in a fixed-dose combination via inhalational route.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886318666221213102924","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T09:31:47Z","timestamp":1671010307000},"page":"534-539","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of Drug Usage Pattern among Bronchial Asthma Patients in a\nTertiary Care Teaching Hospital, Tamilnadu: A Cross-sectional Study"],"prefix":"10.2174","volume":"18","author":[{"given":"Kala","family":"Paneerselvam","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, SRM Medical College Hospital &amp; Research Centre, Kattankulathur, Chengalpet,\nTamilnadu, 603203, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Belur","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, SRM Medical College Hospital &amp; Research Centre, Kattankulathur, Chengalpet,\nTamilnadu, 603203, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamuna Rani","family":"Raveendran","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, SRM Medical College Hospital &amp; Research Centre, Kattankulathur, Chengalpet,\nTamilnadu, 603203, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","year":"2014","unstructured":"British guideline on the management of asthma. Clinical Guideline. British Thoracic Society and Scottish Intercollegiate Guidelines NetworkAvailable from: 2014"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"Vos T.","year":"2020","unstructured":"Vos T.; Lim S.S.; Abbafati C.; Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020,396(10258),1204-1222","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1183\/20734735.026410","volume":"7","author":"Barnes P.J.","year":"2011","unstructured":"Barnes P.J.; Similarities and differences in inflammatory mechanisms of asthma and COPD. Breathe 2011,7(3),229-238","journal-title":"Breathe"},{"key":"ref=4","year":"2018","unstructured":"The global asthma report. Global Asthma NetworkAvailable from:  (Accessed on: Feb 22, 2022).2018"},{"key":"ref=5","first-page":"815","author":"Rodolf M.","year":"2008","unstructured":"Rodolf M.; Pascual, JeRay J Johnson, Stephen P Peters. Asthma: Clinical presentation and Management. In: Fishman\u2019s Pulmonary Diseases and Disorders 2008,815-836","journal-title":"Fishman\u2019s Pulmonary Diseases and Disorders"},{"key":"ref=6","first-page":"907","volume":"5","author":"Haslett C.","year":"2008","unstructured":"Haslett C.; Asthma Cellular and humeral mechanisms. Crofton and Douglass respiratory disease 2008,5,907-921","journal-title":"Crofton and Douglass respiratory disease"},{"key":"ref=7","year":"2006","unstructured":"Global strategy for asthma management and prevention: NHLBI\/WHO workshop report. Global Initiative for Asthma2006"},{"key":"ref=8","year":"2020","unstructured":"Global strategy for asthma management and prevention. Global Initiative for AsthmaAvailable from:  (Accessed on: Feb 22, 2022).2020"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1086\/647001","volume":"16","author":"Patterson C. H.","year":"(1995)","unstructured":"Patterson C. H.; Joint Commission on Accreditation of Healthcare Organizations. Infection control and hospital epidemiology, (1995),16(1),36-42","journal-title":"Infection control and hospital epidemiology,"},{"key":"ref=10","first-page":"257","volume":"36","author":"Kubacka R.T.","year":"1996","unstructured":"Kubacka R.T.; A primer on drug utilization review. J Am Pharm Assoc 1996,36(4),257-261","journal-title":"J Am Pharm Assoc"},{"key":"ref=11","author":"Network G.A.","year":"2018","unstructured":"Network G.A.;  The Global Asthma Report   (Accessed on: 28 Feb 2022).2018","journal-title":"The Global Asthma Report"},{"key":"ref=12","first-page":"53","author":"Kharazi SR","year":"2020","unstructured":"Kharazi SR; Kumar P; Assessment of the Drug Use Evaluation for Bronchial Asthma in a Tertiary Care Hospital, Bangalore, India. Archives of Pharmacy Practice&#xA6; Volume. 2020(S4),53"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/02770909309054520","volume":"30","author":"Montealegre F.","year":"1993","unstructured":"Montealegre F.; Chardon D.; Tarrats H.; Environmental factors precipitating bronchial asthma exacerbations in southern Puerto Rico: a pilot study. J Asthma 1993,30(3),219-227","journal-title":"J Asthma"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/00001648-200109000-00019","volume":"12","author":"London S.J.","year":"2001","unstructured":"London S.J.; James Gauderman W.; Avol E.; Rappaport E.B.; Peters J.M.; Family history and the risk of early-onset persistent, early-onset transient, and late-onset asthma. Epidemiology 2001,12(5),577-583","journal-title":"Epidemiology"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.4103\/jfmpc.jfmpc_288_19","volume":"8","author":"Wani R.","year":"2019","unstructured":"Wani R.; Socioeconomic status scales-modified Kuppuswamy and Udai Pareekh\u2019s scale updated for 2019. J Family Med Prim Care 2019,8(6),1846-1849","journal-title":"J Family Med Prim Care"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1183\/09031936.06.00108105","volume":"28","author":"Hedlund U.","year":"2006","unstructured":"Hedlund U.; Eriksson K.; R&#xF6;nmark E.; Socio-economic status is related to incidence of asthma and respiratory symptoms in adults. Eur Respir J 2006,28(2),303-410","journal-title":"Eur Respir J"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4103\/ijaai.ijaai_17_19","volume":"33","author":"Burute S.R.","year":"2019","unstructured":"Burute S.R.; Shah R.D.; Ramanand S.; Murthy M.; Shah N.; Kumbhar A.; Drug utilization study in patients with bronchial asthma of a tertiary care hospital in Western Maharashtra. Indian J Allergy Asthma Immunol 2019,33(2),105-111","journal-title":"Indian J Allergy Asthma Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4187\/respcare.06714","volume":"65","author":"He Z.","year":"2020","unstructured":"He Z.; Feng J.; Xia J.; Wu Q.; Yang H.; Ma Q.; Frequency of signs and symptoms in persons with asthma. Respir Care 2020,65(2),252-264","journal-title":"Respir Care"},{"key":"ref=19","first-page":"297","volume":"3","author":"Rajathilagam T.","year":"2012","unstructured":"Rajathilagam T.; Sandozi T.; Nageswari A.D.; Paramesh P.; Rani Jamuna R.; Drug utilization study in bronchial asthma in a tertiary care hospital. Int J Pharm Appl 2012,3(2),297-305","journal-title":"Int J Pharm Appl"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.4103\/njcp.njcp_378_16","volume":"20","author":"Rafeeq M.M.","year":"2017","unstructured":"Rafeeq M.M.; Murad H.A.S.; Evaluation of drug utilization pattern for patients of bronchial asthma in a government hospital of Saudi Arabia. Niger J Clin Pract 2017,20(9),1098-1105","journal-title":"Niger J Clin Pract"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.5530\/ijopp.8.1.8","volume":"8","author":"Kumar V.B.","year":"2015","unstructured":"Kumar V.B.; Thankachan T.M.; Amanapu A.; Chandra D.S.; Krishnan S.P.; Study of prescribing pattern and impact of pharmaceutical care in bronchial asthmatic paediatric patients in a tertiary care teaching hospital. Indian Journal of Pharmacy Practice 2015,8(1)","journal-title":"Indian Journal of Pharmacy Practice"},{"key":"ref=22","first-page":"1448","volume":"3","author":"Garje Y.A.","year":"2014","unstructured":"Garje Y.A.; Suman R.K.; Kumar R.; Deshmukh Y.A.; Patra V.; Prescribing patterns and pharmacoeconomic analysis of drugs used in pediatric asthma patients at tertiary care hospital. World J Pharm Pharm Sci 2014,3,1448-1465","journal-title":"World J Pharm Pharm Sci"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/bmjebm-2021-111764","volume":"27","author":"Crossingham I.","year":"2022","unstructured":"Crossingham I.; Turner S.; Ramakrishnan S.; Fries A.; Gowell M.; Yasmin F.; Richardson R.; Webb P.; O\u2019Boyle E.; Hinks T.S.; Combination fixed-dose &#x3B2; agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review. BMJ Evidence-Based Medicine 2022,27(3),178-184","journal-title":"BMJ Evidence-Based Medicine"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886318666221213102924","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211898\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886318666221213102924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T12:09:58Z","timestamp":1691323798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211898\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886318666221213102924","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}